EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, vol.22, no.1, pp.70-73, 2001 (SCI-Expanded)
Article / Article
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
Science Citation Index Expanded (SCI-EXPANDED), Scopus
Istanbul University Affiliated:
Objective: Patients With stage I ovarian cancer show a high incidence of recurrent disease ranging from 30% to 50% which may be associated with ii shortened survival. Therefore. a subset of early-stage patients with poor prognostic factors who are most likely to present with recurrent disease in the next few years may benefit from adjuvant treatment.